Literature DB >> 22809887

Monitoring and evaluating efforts to control hypertension in Canada: why, how, and what it tells us needs to be done about current care gaps.

Norm R C Campbell1, Finlay A McAlister, Hude Quan.   

Abstract

Blood pressure surveillance, monitoring, and evaluation of programs to prevent and control hypertension are critical because increased blood pressure is a leading risk for premature death and disability. Since 2003, the Hypertension Outcomes Research Task Force has existed in Canada, with members who assist in the development and revision of surveys and conduct analyses that help guide hypertension programs. Although the Task Force has tracked a 5-fold increase in the control of hypertension (from 13% in 1985-1992 to 65% in 2007-2009), surveillance data also indicate that many "care gaps" remain. Fifty-four percent of people with diabetes and 34% of those without diabetes have blood pressure readings greater than their target. Treatment rates are high in those who are diagnosed (95%), but 17% of people with hypertension remain undiagnosed. Younger men (more so than women) are too often unaware of having hypertension. Although they are more likely to be aware of their diagnosis, older women are 2 times more likely to have uncontrolled hypertension than men; systolic blood pressure is high in over 80% of those with uncontrolled blood pressure (90% in women); and often people with hypertension are not provided comprehensive advice on healthy behaviours, or assisted in developing plans to control their blood pressure. Many current surveys do not have adequate statistical power to assess vulnerable populations; surveys of Aboriginal populations do not usually assess blood pressure, such that the burden of hypertension in these high risk populations cannot be assessed.
Copyright © 2013 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22809887     DOI: 10.1016/j.cjca.2012.05.006

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  12 in total

1.  World Health Day: focusing on hypertension in 2013.

Authors:  Mark Gelfer; Denis Drouin; Martin Dawes; Norm Campbell
Journal:  Can Fam Physician       Date:  2013-04       Impact factor: 3.275

2.  Hypertension: Silent and/or ignored / L'hypertension silencieuse ou ignorée.

Authors:  Ross T Tsuyuki; Norm Campbell
Journal:  Can Pharm J (Ott)       Date:  2013-03

3.  São Paulo call to action for the prevention and control of high blood pressure: 2020.

Authors:  Norm R C Campbell; Aletta E Schutte; Cherian V Varghese; Pedro Ordunez; Xin-Hua Zhang; Taskeen Khan; James E Sharman; Paul K Whelton; Gianfranco Parati; Michael A Weber; Marcelo Orías; Marc G Jaffe; Andrew E Moran; Frida Liane Plavnik; Venkata S Ram; Michael Brainin; Mayowa O Owolabi; Augstin J Ramirez; Eduardo Barbosa; Luiz Aparecido Bortolotto; Daniel T Lackland
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-11-25       Impact factor: 3.738

Review 4.  Contributions to Hypertension Public Policy and Clinical Practice: A Review of Recent Reports.

Authors:  Michael A Weber; Daniel T Lackland
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-08-20       Impact factor: 3.738

5.  Standards for the uniform reporting of hypertension in adults using population survey data: recommendations from the World Hypertension League Expert Committee.

Authors:  Marianne E Gee; Norm Campbell; Nizal Sarrafzadegan; Tazeen Jafar; Tej K Khalsa; Birinder Mangat; Neil Poulter; Dorairaj Prabhakaran; Sandor Sonkodi; Paul K Whelton; Mark Woodward; Xin-Hua Zhang
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-08-26       Impact factor: 3.738

6.  Is reducing dietary sodium controversial? Is it the conduct of studies with flawed research methods that is controversial? A perspective from the World Hypertension League Executive Committee.

Authors:  Norm R C Campbell; Daniel T Lackland; Mark L Niebylski; Peter M Nilsson
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-11-06       Impact factor: 3.738

7.  [São Paulo call to action for the prevention and control of high blood pressure: 2020Chamado à ação de São Paulo para prevenção e controle da hipertensão arterial: 2020].

Authors:  Norm Rc Campbell; Aletta E Schutte; Cherian V Varghese; Pedro Ordunez; Xin-Hua Zhang; Taskeen Khan; James E Sharman; Paul K Whelton; Gianfranco Parati; Michael A Weber; Marcelo Orías; Marc G Jaffe; Andrew E Moran; Frida Liane Plavnik; Venkata S Ram; Michael Brainin; Mayowa O Owolabi; Agustin J Ramirez; Eduardo Barbosa; Luiz Aparecido Bortolotto; Daniel T Lackland
Journal:  Rev Panam Salud Publica       Date:  2021-02-26

8.  Implementing standardized performance indicators to improve hypertension control at both the population and healthcare organization levels.

Authors:  Norm Campbell; Pedro Ordunez; Marc G Jaffe; Marcelo Orias; Donald J DiPette; Pragna Patel; Nadia Khan; Oyere Onuma; Daniel T Lackland
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-02-13       Impact factor: 3.738

9.  Socio-demographic caracteristics and prevalence of risk factors in a hypertensive and diabetics population: a cross-sectional study in primary health care in Brazil.

Authors:  Julio Baldisserotto; Luciane Kopittke; Fulvio Borges Nedel; Silvia Pasa Takeda; Claunara Schilling Mendonça; Sérgio Antonio Sirena; Margarita Silva Diercks; Lena Azeredo de Lima; Belinda Nicolau
Journal:  BMC Public Health       Date:  2016-07-15       Impact factor: 3.295

10.  Primary care EMR and administrative data linkage in Alberta, Canada: describing the suitability for hypertension surveillance.

Authors:  Stephanie Garies; Erik Youngson; Boglarka Soos; Brian Forst; Kimberley Duerksen; Donna Manca; Kerry McBrien; Neil Drummond; Hude Quan; Tyler Williamson
Journal:  BMJ Health Care Inform       Date:  2020-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.